Description
The triple threat — Retatrutide engages GLP-1, GIP and glucagon receptors at once. A next-generation agonist under study for the strongest metabolic and weight responses recorded yet. Lyophilized powder, 3 mL vial. For research use only.
● Member rewards
Members save up to 30%.
Create a free account — discounts apply automatically at checkout.
10%
Create an account
+10%
3 or more units
20%
Orders over $1,000
10% ea
Refer a friend — both save
Retatrutide 20 mg (APEX)
$180.00
Triple GLP-1 / GIP / Glucagon · 20 mg vial · ≥ 99% HPLC
Certificate of Analysis.
PASS · 99.94%Identity (LC-MS)Retatrutide — Confirmed (LC-MS)
Purity (HPLC-UV)99.94%
Net peptide9.21 mg
AppearanceWhite lyophilized powder
Tested byFreedom Diagnostics
Lot2606150438
Reported17 JUN 2026
Reviews
There are no reviews yet.